These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26777280)

  • 1. The N-terminal domain of the GluN3A subunit determines the efficacy of glycine-activated NMDA receptors.
    Mesic I; Madry C; Geider K; Bernhard M; Betz H; Laube B
    Neuropharmacology; 2016 Jun; 105():133-141. PubMed ID: 26777280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
    Kvist T; Greenwood JR; Hansen KB; Traynelis SF; Bräuner-Osborne H
    Neuropharmacology; 2013 Dec; 75():324-36. PubMed ID: 23973313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative allosteric modulation of GluN1/GluN3 NMDA receptors.
    Zhu Z; Yi F; Epplin MP; Liu D; Summer SL; Mizu R; Shaulsky G; XiangWei W; Tang W; Burger PB; Menaldino DS; Myers SJ; Liotta DC; Hansen KB; Yuan H; Traynelis SF
    Neuropharmacology; 2020 Oct; 176():108117. PubMed ID: 32389749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protons Potentiate GluN1/GluN3A Currents by Attenuating Their Desensitisation.
    Cummings KA; Popescu GK
    Sci Rep; 2016 Mar; 6():23344. PubMed ID: 27000430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site.
    Kvist T; Steffensen TB; Greenwood JR; Mehrzad Tabrizi F; Hansen KB; Gajhede M; Pickering DS; Traynelis SF; Kastrup JS; Bräuner-Osborne H
    J Biol Chem; 2013 Nov; 288(46):33124-35. PubMed ID: 24072709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmasking GluN1/GluN3A excitatory glycine NMDA receptors.
    Grand T; Abi Gerges S; David M; Diana MA; Paoletti P
    Nat Commun; 2018 Nov; 9(1):4769. PubMed ID: 30425244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectins modulate the functional properties of GluN1/GluN3-containing NMDA receptors.
    Hemelikova K; Kolcheva M; Skrenkova K; Kaniakova M; Horak M
    Neuropharmacology; 2019 Oct; 157():107671. PubMed ID: 31202607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-channel blockade is less effective on GluN3B than GluN3A subunit-containing NMDA receptors.
    McClymont DW; Harris J; Mellor IR
    Eur J Pharmacol; 2012 Jul; 686(1-3):22-31. PubMed ID: 22564863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonists.
    Rouzbeh N; Rau AR; Benton AJ; Yi F; Anderson CM; Johns MR; Jensen L; Lotti JS; Holley DC; Hansen KB
    J Gen Physiol; 2023 Jun; 155(6):. PubMed ID: 37078900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation-induced structural change in the GluN1/GluN3A excitatory glycine receptor.
    Balasuriya D; Takahashi H; Srivats S; Edwardson JM
    Biochem Biophys Res Commun; 2014 Aug; 450(4):1452-7. PubMed ID: 25017909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residues in the GluN1 C-terminal domain control kinetics and pharmacology of GluN1/GluN3A N-methyl-d-aspartate receptors.
    Cummings KA; Belin S; Popescu GK
    Neuropharmacology; 2017 Jun; 119():40-47. PubMed ID: 28365212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of aversion by glycine-gated GluN1/GluN3A NMDA receptors in the adult medial habenula.
    Otsu Y; Darcq E; Pietrajtis K; Mátyás F; Schwartz E; Bessaih T; Abi Gerges S; Rousseau CV; Grand T; Dieudonné S; Paoletti P; Acsády L; Agulhon C; Kieffer BL; Diana MA
    Science; 2019 Oct; 366(6462):250-254. PubMed ID: 31601771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors.
    Madry C; Mesic I; Betz H; Laube B
    Mol Pharmacol; 2007 Dec; 72(6):1535-44. PubMed ID: 17878266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of GluN1-3A NMDA receptor excitatory glycine receptor channel.
    Michalski K; Furukawa H
    Sci Adv; 2024 Apr; 10(15):eadl5952. PubMed ID: 38598639
    [No Abstract]   [Full Text] [Related]  

  • 15. Triheteromeric N-methyl-D-aspartate receptors differentiate synaptic inputs onto pyramidal neurons in somatosensory cortex: involvement of the GluN3A subunit.
    Pilli J; Kumar SS
    Neuroscience; 2012 Oct; 222():75-88. PubMed ID: 22814002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of M4 Transmembrane Segments in NMDA Receptor Function: A Negative Allosteric Modulatory Site at the GluN1 M4 is Determining the Efficiency of Neurosteroid Modulation.
    Langer K; Müller-Längle A; Wempe J; Laube B
    Front Pharmacol; 2021; 12():769046. PubMed ID: 34658899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural features in the glycine-binding sites of the GluN1 and GluN3A subunits regulate the surface delivery of NMDA receptors.
    Skrenkova K; Hemelikova K; Kolcheva M; Kortus S; Kaniakova M; Krausova B; Horak M
    Sci Rep; 2019 Aug; 9(1):12303. PubMed ID: 31444392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Subtype-Selective Allosteric Inhibitor of GluN1/GluN3 NMDA Receptors.
    Zeng Y; Zheng Y; Zhang T; Ye F; Zhan L; Kou Z; Zhu S; Gao Z
    Front Pharmacol; 2022; 13():888308. PubMed ID: 35754487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function.
    Madry C; Mesic I; Bartholomäus I; Nicke A; Betz H; Laube B
    Biochem Biophys Res Commun; 2007 Mar; 354(1):102-8. PubMed ID: 17214961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitatory GluN1/GluN3A glycine receptors (eGlyRs) in brain signaling.
    Bossi S; Pizzamiglio L; Paoletti P
    Trends Neurosci; 2023 Aug; 46(8):667-681. PubMed ID: 37248111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.